NASTA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.073
EU - Europa 305
AS - Asia 289
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 1.673
Nazione #
US - Stati Uniti d'America 1.062
CN - Cina 146
UA - Ucraina 107
SG - Singapore 81
DE - Germania 57
HK - Hong Kong 36
FI - Finlandia 35
IT - Italia 34
GB - Regno Unito 27
IE - Irlanda 16
TR - Turchia 14
CA - Canada 11
IN - India 11
FR - Francia 10
BE - Belgio 9
SE - Svezia 6
EU - Europa 4
CZ - Repubblica Ceca 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
KZ - Kazakistan 1
NL - Olanda 1
Totale 1.673
Città #
Fairfield 148
Woodbridge 134
Ashburn 110
Jacksonville 87
Singapore 74
Wilmington 65
Ann Arbor 61
Seattle 57
Chandler 56
Houston 47
Cambridge 46
Hong Kong 36
Nanjing 32
Princeton 32
Beijing 28
Helsinki 24
Dearborn 22
New York 17
Dublin 16
Istanbul 13
Los Angeles 13
Washington 13
Changsha 12
Nanchang 11
Brussels 9
Milan 9
Toronto 9
Jiaxing 8
Jinan 8
Lancaster 8
San Diego 8
Shenyang 7
Tianjin 7
Shanghai 6
Hebei 5
Monmouth Junction 5
Des Moines 4
Ningbo 4
San Francisco 4
Brescia 3
Munich 3
Zhengzhou 3
Brno 2
Chiswick 2
Leawood 2
London 2
Ottawa 2
Polaveno 2
Ronciglione 2
San Mateo 2
Taiyuan 2
Taizhou 2
Augusta 1
Berlin 1
Boardman 1
Charlotte 1
Como 1
Dallas 1
Eindhoven 1
Fuzhou 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hefei 1
Kocaeli 1
Kunming 1
Lanzhou 1
Melbourne 1
Orange 1
Pescara 1
Pune 1
Redmond 1
Rochester 1
Santa Clara 1
Shaoxing 1
Tirana 1
Verona 1
Walnut 1
Totale 1.310
Nome #
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 140
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 132
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 126
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis 125
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. 122
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 122
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. 112
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 112
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. 103
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 103
Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015 92
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 87
Studio di coorte multicentrico per l'analisi dei fattori che influenzano la risposta alla terapia antivirale in pazienti HCV positivi: risultati del primo anno di attività. 76
Treating hepatitis C virus in HIV patients: are side effects a real obstacle? 70
Rapid Virologic Response (RVR), IL28B Single Nucleotide Polymorphism (SNP) rs12980275 and HCV genotype are independent predictors of Sustained Virologic Response (SVR) in HIV/HCV coinfected patients treated with Pegylated Interferon and Ribavirin. 70
Studio di affidabilità sul consumo di alcol, caffè e abitudine al fumo in pazienti HCV postivi. 66
Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection 46
Totale 1.704
Categoria #
all - tutte 7.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020275 0 0 0 0 0 49 50 44 28 66 14 24
2020/2021249 2 26 18 48 11 26 7 27 30 24 23 7
2021/2022162 24 15 5 9 2 11 4 14 7 17 20 34
2022/2023165 21 2 1 15 10 45 0 18 32 2 7 12
2023/2024200 11 7 31 17 18 52 5 6 37 4 0 12
2024/2025134 2 7 0 58 64 3 0 0 0 0 0 0
Totale 1.704